{
    "nctId": "NCT02769364",
    "briefTitle": "Extended Treatment in Metastatic Breast Cancer With Eribulin",
    "officialTitle": "Long-term Eribulin Treatment in Metastatic Breast Cancer: A Multicenter, Case-study Analysis",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Overall survival",
    "eligibilityCriteria": "Inclusion criteria:\n\n* Participants with Advanced or Metastatic Breast Cancer on Eribulin for at least 7 months\n\nExclusion criteria:\n\n* Lack of accessible clinical records",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}